GSK plc (GSK)

業務介紹

葛蘭素史克公司及其子公司在英國、美國和國際上從事製藥產品、疫苗、非處方藥品和與健康相關的消費品的創造、發現、開發、製造和營銷。該公司通過四個部門運營:製藥、製藥研發、疫苗和消費者保健。該公司提供的製藥產品包括治療領域的藥物,如呼吸系統、HIV、免疫炎症、腫瘤學、抗病毒、中樞神經系統、心血管和泌尿生殖系統、代謝、抗細菌和皮膚病。它還提供保健品,涵蓋保健、口腔健康、營養和皮膚健康等類別。該公司以噴霧劑、片劑、糖漿、喉片、口香糖和經皮貼片、膠囊、嬰兒糖漿滴劑、液體懸浮液、濕巾、凝膠、泡騰劑、牙膏、牙刷、漱口水、假牙黏合劑和清潔劑、外用乳膏和非藥用貼片、潤唇膏、軟糖和軟咀嚼片的形式提供其消費者保健產品。該公司與23andMe、Lyell Immunopharma, Inc.、諾華、賽諾菲SA、Surface Oncology、Progentec Diagnostics, Inc.、Alector, Inc.和CureVac AG.有合作協議,並與IDEAYA Biosciences, Inc.和Vir Biotechnology, Inc.有戰略合作夥伴關係。該公司曾稱為葛蘭素史克公司,於2022年5月更名為GSK公司。GSK公司成立於1715年,總部位於英國倫敦郊區的布倫特福德。



GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

公司網址

https://www.gsk.com